Cite
HARVARD Citation
Manti, S. et al. (2021). Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review. Immunity, inflammation and disease. 9 (1), pp. 3-7. [Online].